Most bought healthcare stocks in Q4 2018
See which Healthcare stocks institutional investors increased the most in Q4 2018, measured as net growth in reported share positions from Q3 2018 into Q4 2018. Notable additions at the top of this list include AKEBIA THERAPEUTICS INC (AKBA), MODERNA INC (MRNA), THE CIGNA GROUP (CI), BRISTOL-MYERS SQUIBB CO (BMY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| AKBA | AKEBIA THERAPEUTICS INC | 27,231,658 | $141.03M | 1 | 1 | 0 | 1 | 2 |
| MRNA | MODERNA INC | 17,081,164 | $260.83M | 1 | 0 | 0 | 0 | 1 |
| CI | THE CIGNA GROUP | 15,238,721 | $2.89B | 4 | 0 | 0 | 0 | 4 |
| BMY | BRISTOL-MYERS SQUIBB CO | 5,563,153 | -$177.62M | 0 | 1 | 5 | 1 | 9 |
| INCY | INCYTE CORP | 3,739,004 | $234.12M | 1 | 1 | 1 | 0 | 3 |
| UNH | UNITEDHEALTH GROUP INC | 3,070,324 | $429.72M | 1 | 3 | 9 | 1 | 15 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 2,479,215 | -$391.30M | 0 | 3 | 1 | 0 | 6 |
| EXAS | EXACT SCIENCES CORP | 2,416,163 | $128.04M | 0 | 1 | 0 | 1 | 1 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 2,204,384 | $37.08M | 1 | 0 | 0 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | 2,025,102 | $5.87M | 0 | 1 | 1 | 0 | 2 |
| DVA | DAVITA INC | 1,975,829 | -$691.83M | 1 | 0 | 0 | 1 | 3 |
| EXEL | EXELIXIS INC | 1,821,017 | $43.81M | 0 | 1 | 0 | 0 | 1 |
| AMRX | AMNEAL PHARMACEUTICALS INC | 1,388,629 | $2.18M | 0 | 2 | 0 | 0 | 2 |
| A | AGILENT TECHNOLOGIES INC | 1,381,511 | $77.63M | 1 | 2 | 0 | 0 | 4 |
| NTLA | INTELLIA THERAPEUTICS INC | 1,276,162 | -$68.71M | 1 | 1 | 0 | 0 | 2 |
| VREX | VAREX IMAGING CORP | 1,252,612 | $28.82M | 1 | 0 | 1 | 0 | 2 |
| BKD | BROOKDALE SENIOR LIVING INC | 1,220,701 | -$4.28M | 0 | 1 | 0 | 0 | 1 |
| BSX | BOSTON SCIENTIFIC CORP | 1,183,684 | $28.32M | 0 | 1 | 2 | 1 | 3 |
| BPMC | BLUEPRINT MEDICINES CORP | 1,089,222 | $56.04M | 0 | 1 | 0 | 0 | 1 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 1,083,870 | $28.86M | 0 | 2 | 0 | 0 | 2 |
| ARDX | ARDELYX INC | 1,017,721 | -$1.20M | 0 | 1 | 0 | 0 | 1 |
| TNDM | TANDEM DIABETES CARE INC | 1,016,733 | $36.68M | 0 | 1 | 0 | 0 | 1 |
| ILMN | ILLUMINA INC | 929,383 | $232.08M | 1 | 2 | 1 | 0 | 4 |
| PINC | PREMIER INC-CLASS A | 837,148 | $18.08M | 0 | 1 | 1 | 0 | 2 |
| ALKS | ALKERMES PLC | 794,401 | $23.44M | 1 | 0 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 786,664 | $12.93M | 0 | 1 | 2 | 0 | 3 |
| PTCT | PTC THERAPEUTICS INC | 740,100 | $21.82M | 0 | 1 | 0 | 0 | 1 |
| INVA | INNOVIVA INC | 732,054 | $26.66M | 0 | 1 | 1 | 0 | 2 |
| LGND | LIGAND PHARMACEUTICALS | 726,600 | -$6.08M | 0 | 1 | 0 | 0 | 1 |
| MASI | MASIMO CORP | 716,721 | $71.69M | 1 | 2 | 0 | 0 | 3 |
| SRNE | SORRENTO THERAPEUTICS INC | 710,847 | $1.39M | 0 | 1 | 0 | 0 | 2 |
| EHC | ENCOMPASS HEALTH CORP | 662,800 | $16.32M | 0 | 2 | 0 | 0 | 2 |
| TDOC | TELADOC HEALTH INC | 645,716 | $28.71M | 1 | 1 | 0 | 0 | 2 |
| GILD | GILEAD SCIENCES INC | 633,383 | -$485.29M | 0 | 4 | 3 | 1 | 8 |
| RGNX | REGENXBIO INC | 598,443 | $15.49M | 0 | 1 | 0 | 0 | 1 |
| TGTX | TG THERAPEUTICS INC | 523,400 | $1.62M | 0 | 1 | 0 | 0 | 1 |
| HQY | HEALTHEQUITY INC | 498,734 | $24.28M | 0 | 1 | 0 | 0 | 1 |
| CLSD | CLEARSIDE BIOMEDICAL INC | 471,324 | $326.00K | 0 | 1 | 0 | 0 | 1 |
| VNDA | VANDA PHARMACEUTICALS INC | 462,700 | $18.61M | 0 | 1 | 0 | 0 | 1 |
| ZTS | ZOETIS INC | 441,298 | -$53.88M | 0 | 3 | 1 | 0 | 5 |
| BIIB | BIOGEN INC | 433,015 | $80.80M | 1 | 3 | 0 | 2 | 5 |
| ACAD | ACADIA PHARMACEUTICALS INC | 425,500 | $6.09M | 0 | 1 | 0 | 0 | 1 |
| CARA | CARA THERAPEUTICS INC | 410,851 | -$3.96M | 1 | 0 | 1 | 0 | 2 |
| RVNC | REVANCE THERAPEUTICS INC | 395,419 | $7.13M | 0 | 1 | 0 | 0 | 1 |
| DXCM | DEXCOM INC | 391,529 | $33.35M | 0 | 1 | 0 | 0 | 1 |
| STAA | STAAR SURGICAL CO | 369,800 | -$2.78M | 0 | 1 | 0 | 0 | 1 |
| VYGR | VOYAGER THERAPEUTICS INC | 356,901 | $2.64M | 0 | 1 | 0 | 0 | 1 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 355,553 | $2.79M | 0 | 1 | 0 | 0 | 1 |
| NKTR | NEKTAR THERAPEUTICS | 333,100 | $9.02M | 0 | 1 | 0 | 0 | 1 |
| HUM | HUMANA INC | 333,000 | -$69.82M | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q4 2018
What are the most bought Healthcare stocks in Q4 2018?
The most bought healthcare stocks in Q4 2018 are those with the largest increase in reported share counts across institutional investors compared to Q3 2018, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2018?
Among filers in this sector, net additions were largest in companies such as AKEBIA THERAPEUTICS INC (AKBA), MODERNA INC (MRNA), THE CIGNA GROUP (CI), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2018).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.